RSS   Newsletter   Contact   Advertise with us
Post Online Media

Aerie Pharmaceuticals appoints chief commercial officer

Aerie PharmaceuticalsAerie Pharmaceuticals, a clinical-stage pharmaceutical company, announced the appointment of Judith J. Robertson as chief commercial officer.
Article continues below

READ MORE Aerie Pharmaceuticals names president and COO

Ms. Robertson will be responsible for leading the global commercialization of Aerie’s ophthalmology franchise.

Ms. Robertson joins Aerie from the Janssen Pharmaceutical Companies of Johnson & Johnson, where she has been the VP of Global Immunology, Ophthalmology and Global Analytics since 2013.

Prior to Janssen, Ms. Robertson was VP of Global Ophthalmology at Alcon, VP of Global Respiratory at Novartis, and President of Bristol Myers Squibb Canada.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy